Skip to main content
Filiz Sen, MD, Pathology, New York, NY

Filiz Sen MD

Pathology•New York, NY

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology and Laboratory Medicine, Hofstra North Shore-LIJ

Request Appointment

  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(484) 859-0719

Overview of  Dr. Sen

Dr. Filiz Sen is a pathologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Glen Cove Hospital. She received her medical degree from Marmara University Faculty of Medicine and has been in practice 27 years. She is one of 25 doctors at Glen Cove Hospital and one of 157 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pathology. She has more than 30 publications and over 500 citings.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1998 - 2002
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pathology-Anatomic and Clinical, 1995 - 1998
  • Marmara Univ- Fac Med
    Marmara Univ- Fac MedClass of 1990

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2002 - Present
  • NJ State Medical License
    NJ State Medical License 2021 - 2027
  • NY State Medical License
    NY State Medical License 2010 - 2027
  • NC State Medical License
    NC State Medical License 2004 - 2006
  • Anatomic Pathology & Clinical Pathology
    American Board of Pathology Anatomic Pathology & Clinical Pathology
  • Hematology
    American Board of Pathology Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Dual Driver Mutant BCR-ABL1-Negative Myeloid Neoplasms: Multicenter Clinicopathologic and Genomic Analysis
    Filiz Sen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
    Filiz Sen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Selinexor, a First-in-Class XPO1 Inhibitor, Is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Filiz Sen, Dr. Filiz Sen, MD, Dr. F Sen